Elevated CD21low B Cell Frequency is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 Mrna Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency.
Journal of Clinical Immunology（2022）
Key words
CD21(low) B-cells,Pfizer-BioNTech BNT162b2 mRNA vaccine,COVID-19,SARS-CoV-2,CVID
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined